Effects of doxazosin on blood pressure, renin-angiotensin-aldosterone and urinary kallikrein
- 15 January 1991
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 67 (2) , 157-161
- https://doi.org/10.1016/0002-9149(91)90438-q
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efectiveness of doxazosin in systemic hyperftensionThe American Journal of Cardiology, 1989
- Pharmacokinetic overview of doxazosinThe American Journal of Cardiology, 1987
- Role of Alpha Adrenoceptors in Hypertension and in Anti hypertensive Drug TreatmentThe American Journal of Medicine, 1984
- Doxazosin, an alpha 1‐adrenoceptor antagonist: pharmacokinetics and concentration‐effect relationships in man.British Journal of Clinical Pharmacology, 1983
- Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart FailureDrugs, 1983
- A pharmacodynamic and pharmacokinetic assessment of a new alpha‐ adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.British Journal of Clinical Pharmacology, 1982
- Postjunctional Selectivity of α-Blockade with Prazosin, Trimazosin, and UK-33,274 in ManJournal of Cardiovascular Pharmacology, 1982
- Studies on the renin-aldosterone system in the acute nephritic syndromeKidney International, 1981
- Central and Renal Circulation, Renin and Aldosterone in Plasma during Prazosin Treatment in Essential HypertensionActa Medica Scandinavica, 1979
- Prazosin: the first-dose phenomenon.BMJ, 1976